GSK's John Baldoni talks to Scrip in an exclusive interview about taking over the big pharma's artificial intelligence R&D strategy and the company's early-stage progress using machine-driven discovery and development methods. Already Registered? Sign in to continue reading. Sign In. Thanks, we've …
Link to Full Article: Read Here
